Left Bundle Branch Area Pacing in Patients With Heart Failure

NCT06488989 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-07-05

No results posted yet for this study

Summary

The relevance of Left Bundle Branch Pacing (LBBP) lies in its potential as a promising treatment option for patients with heart failure and left bundle branch block. LBBP aims to restore the normal physiological activation of the heart by delivering electrical impulses to the anatomical area of the left bundle branch, which may lead to more effective and synchronized ventricular contractions. Compared to traditional cardiac resynchronization therapy (CRT), this can result in a more physiological correction of dyssynchrony, improvement in left ventricular pump function, reduction in left ventricular volumes, and a decrease in mitral regurgitation. A crucial criterion is the reduction of heart failure symptoms and the enhancement of the patients quality of life.

Conditions

  • Heart Failure With Reduced Ejection Fraction
  • Left Bundle Branch Area Pacing
  • Heart Failure
  • Cardiac Resynchronization Therapy
  • Cardiac Resynchronization Therapy Devices
  • Conduction System Pacing
  • Left Bundle-Branch Block

Interventions

DEVICE

left bundle branch area pacing

Cardiac resynchronization therapy obtained by conduction system pacing

Sponsors & Collaborators

  • National Research Center for Cardiac Surgery, Kazakhstan

    lead OTHER

Principal Investigators

  • Yerlan Turubayev, MD · doctor

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-06-01
Completion
2026-06-01

Countries

  • Kazakhstan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06488989 on ClinicalTrials.gov